Kevin P. Starr - Jun 16, 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Director
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kevin P. Starr
Stock symbol
SAGE
Transactions as of
Jun 16, 2021
Transactions value $
$999,983
Form type
4
Date filed
6/17/2021, 09:15 AM
Previous filing
Jun 11, 2021
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Purchase $1M +17.8K +5.89% $56.05 321K Jun 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $56.0447 USD to $56.9527 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.